Cargando…

COVID-19 and literature evidence: should we publish anything and everything?

COVID-19 first presented in Wuhan, Hubei Province, China in December 2019. Since then, it has rapidly spread across the world, and is now formally considered a pandemic. As of 4(th) of May more than 3.2 million people have been infected and over 250,000 people have died. Since the very start, scient...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Jeremy, Oo, Shwe, Chor, Cheryl Yan Ting, Yim, Daniel, Chan, Jeffrey Shi Kai, Harky, Amer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717020/
https://www.ncbi.nlm.nih.gov/pubmed/32921717
http://dx.doi.org/10.23750/abm.v91i3.9827
Descripción
Sumario:COVID-19 first presented in Wuhan, Hubei Province, China in December 2019. Since then, it has rapidly spread across the world, and is now formally considered a pandemic. As of 4(th) of May more than 3.2 million people have been infected and over 250,000 people have died. Since the very start, scientists and researchers have tried to utilize this case to publish academic experiences and suggestions toward fighting this virus, which is lethal in some cases. To date, more than 9,000 academic papers have been published since December 2019. The quality of publications varies from a plane letter to the editor to randomized studies. This review aims to analyse the current published literature related to COVID-19 and assess the quality of such articles. (www.actabiomedica.it)